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Introduction Development of 3D hepatic organoids utilising human
cell derivatives for in vitro drug testing and bioartificial liver support
systems is challenging. Tissue engineering thick, complex structures
such as human liver organoids (micro-tissue; >500 mm) will require
vascularisation of 3D culturesdcoupled with biomatrix support
scaffoldsdto both maintain integrity and promote formation of
endothelial channels (sinusoid-like structures) to facilitate oxygen
and nutrient transfer to hepatocytes in 3D culture. Key challenges
involve directing nascent microvessels into an appropriate environ-
ment defined prominently by heterotypic cellecell contacts and
meeting high metabolic demands. In this preliminary study, we
aimed to optimise heterotypic co-culture of either Human Umbilical
Vein Endothelial Cells (HUVECs) or Endothelial Outgrowth Cells
(EOCs) with hepatic C3A cells, using appropriate biomatrix
scaffolds.
Methods Different ratios of HUVECs: C3A or EOCs:C3A to form
co-cultures were studied using contrast/confocal microscopy and
flow cytometry following appropriate immunostaining. Flow
cytometry was used to study integrin expression (Cd49a, Cd49b,
Cd49f, Cd49e), endothelial markers (CD31) and EpCam, as an
hepatic marker. Fingerprint unbiased metabolomics analysis was
used to assess function of co-cultured cells. Matrigel and MaxGel
(Sigma) were tested as candidate bioscaffolds and were compared
with standard 2D cultures on plastic and collagen for each cell line
as controls.
Results A ratio 3:1 (HUVECs:C3A) was optimal for growth using
endothelial culture medium (Lonza EGM-2 medium, UK). Cell
phenotype was maintained for 7 days in co-culture with strong
integrin (Cd49a, Cd49b, Cd49f, Cd49e), and CD31 expression on
HUVECs and EpCam on C3A cells, while a reduction of HUVEC cell
number was noted with a parallel increase of C3A cells by day 7dto
form more sheet-like structures in co-culture. Metabolomics anal-
ysis of culture media showed enhanced urea cycle, lipid synthesis
and amino acid utilisation of C3A cells in co-culture. Matrigel
promoted formation of microvessel structures, with interconnected
channels, in both EOCs and HUVECs; and was superior to MaxGel.
MaxGel in 3D sandwich culture promoted differentiated (cuboidal)
morphology of C3As, but not EoCs.
Conclusion Optimisation of both cell ratios and cell numbers, as well
as selection of appropriate culture media are critical factors in
developing a successful hepatic co-culture system with the ability to
form sinusoid-like/microvessel structures. This study represents an
early step towards understanding the requirements of vascularised
liver tissue for future clinical/pharmaceutical applications.
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Introduction Diagnosis of overt hepatic encephalopathy (HE) in
patients with cirrhosis often relies on subjective clinical examina-
tion. Arterial ammonia correlates poorly with HE grades and a blood
marker for diagnosis and monitoring is lacking. Metabolic profiling
by nuclear magnetic resonance (NMR) spectroscopy of blood
correlates with Model for End Stage Liver Disease Score (MELD)1
and may offer diagnostic biomarkers in overt HE.
Methods Thirty-seven patients with cirrhosis and differing grades of
HE were identified. Arterial blood was drawn for arterial ammonia,
blood gas analysis and NMR spectroscopy. HE was diagnosed and
graded by West-Haven criteria and Trail Making (A and B) Tests. 1H
NMR spectroscopy was performed in a Bruker 600 MHz Avance
spectrometer using a Carr-Purcell-Meiboom-Gill sequence prior to
multivariate analysis using orthogonal partial least squares
discriminant analysis (OPLS-DA).
Results 24 male and 13 female patients, 21 with alcohol-related
cirrhosis, 5 viral hepatitis, 11 mixed/other causes, with median
(range) age 57 (35e75) years made up the study cohort. Fifteen
patients had no HE while 15 had grades 1e2 and 7 grades 3e4.
Median MELD score was 14 (4e32) and median arterial ammonia
level 106 (19e268 mmol/L). Ammonia level correlated weakly with
HE grade (Kendall’s s¼0.238, p¼0.040) but not with MELD score
(s¼0.010, p¼0.118). No multivariate models using HE grade as a
categorical (OPLSDA) or continuous (OPLS) variables resulted
in validity (eg, OPLS model: R2(Y)¼0.489, Q2(Y)¼0.091). A
2-component OPLS model using ammonia as a Y variable identified
multiple metabolites correlating with arterial ammonia (overall R2
(Y)¼0.566, Q2(Y)¼0.394, cross-validated ANOVA p¼0.0008).
Metabolites associated with high ammonia levels included pyruvate,
3-hydroxybutyrate, glutamate, phenylalanine and an unassigned
resonance at 2.43 ppm, while the resonances associated with
lipoproteins correlated negatively with ammonia.
Conclusion Plasma 1H NMR spectroscopy did not discriminate
effectively between grades of HE in this cohort of patients with
cirrhosis and overt HE. Multiple metabolites correlate with arterial
ammonia level with some overlap from the metabolic pathways
implicated in high MELD patients. Alternative metabolic profiling
techniques such as mass spectroscopy may be required to assist in
diagnosis in these patients.
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Introduction Acute-on-chronic liver failure is associated with a high
mortality and difficulty in outcome prediction. Neither liver specific
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